116 related articles for article (PubMed ID: 28181383)
1. Slowly on, Slowly off: Bisubstrate-Analogue Conjugates of 5-Iodotubercidin and Histone H3 Peptide Targeting Protein Kinase Haspin.
Kestav K; Viht K; Konovalov A; Enkvist E; Uri A; Lavogina D
Chembiochem; 2017 Apr; 18(8):790-798. PubMed ID: 28181383
[TBL] [Abstract][Full Text] [Related]
2. Bisubstrate inhibitor approach for targeting mitotic kinase Haspin.
Kestav K; Lavogina D; Raidaru G; Chaikuad A; Knapp S; Uri A
Bioconjug Chem; 2015 Feb; 26(2):225-34. PubMed ID: 25595038
[TBL] [Abstract][Full Text] [Related]
3. Co-crystal structures of the protein kinase haspin with bisubstrate inhibitors.
Lavogina D; Kestav K; Chaikuad A; Heroven C; Knapp S; Uri A
Acta Crystallogr F Struct Biol Commun; 2016 May; 72(Pt 5):339-45. PubMed ID: 27139824
[TBL] [Abstract][Full Text] [Related]
4. Structure, Roles and Inhibitors of a Mitotic Protein Kinase Haspin.
Kestav K; Uri A; Lavogina D
Curr Med Chem; 2017; 24(21):2276-2293. PubMed ID: 28413956
[TBL] [Abstract][Full Text] [Related]
5. Exploring the thermodynamic, kinetic and inhibitory mechanisms of 5-iTU targeting mitotic kinase haspin by integrated molecular dynamics.
Wang Q; Zhang Q; Leung ELH; Chen Y; Yao X
Phys Chem Chem Phys; 2021 Sep; 23(34):18404-18413. PubMed ID: 34612381
[TBL] [Abstract][Full Text] [Related]
6. A small-molecule inhibitor of Haspin alters the kinetochore functions of Aurora B.
De Antoni A; Maffini S; Knapp S; Musacchio A; Santaguida S
J Cell Biol; 2012 Oct; 199(2):269-84. PubMed ID: 23071153
[TBL] [Abstract][Full Text] [Related]
7. Haspin-dependent and independent effects of the kinase inhibitor 5-Iodotubercidin on self-renewal and differentiation.
Karanika E; Soupsana K; Christogianni A; Stellas D; Klinakis A; Politou AS; Georgatos S
Sci Rep; 2020 Jan; 10(1):232. PubMed ID: 31937797
[TBL] [Abstract][Full Text] [Related]
8. Structure and functional characterization of the atypical human kinase haspin.
Eswaran J; Patnaik D; Filippakopoulos P; Wang F; Stein RL; Murray JW; Higgins JM; Knapp S
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20198-203. PubMed ID: 19918057
[TBL] [Abstract][Full Text] [Related]
9. Coumestrol Epigenetically Suppresses Cancer Cell Proliferation: Coumestrol Is a Natural Haspin Kinase Inhibitor.
Kim JE; Lee SY; Jang M; Choi HK; Kim JH; Chen H; Lim TG; Dong Z; Lee KW
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064398
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the chromatin phosphoproteome by the Haspin protein kinase.
Maiolica A; de Medina-Redondo M; Schoof EM; Chaikuad A; Villa F; Gatti M; Jeganathan S; Lou HJ; Novy K; Hauri S; Toprak UH; Herzog F; Meraldi P; Penengo L; Turk BE; Knapp S; Linding R; Aebersold R
Mol Cell Proteomics; 2014 Jul; 13(7):1724-40. PubMed ID: 24732914
[TBL] [Abstract][Full Text] [Related]
11. The kinase haspin is required for mitotic histone H3 Thr 3 phosphorylation and normal metaphase chromosome alignment.
Dai J; Sultan S; Taylor SS; Higgins JM
Genes Dev; 2005 Feb; 19(4):472-88. PubMed ID: 15681610
[TBL] [Abstract][Full Text] [Related]
12. 3H-pyrazolo[4,3-f]quinoline haspin kinase inhibitors and anticancer properties.
Opoku-Temeng C; Dayal N; Aflaki Sooreshjani M; Sintim HO
Bioorg Chem; 2018 Aug; 78():418-426. PubMed ID: 29698892
[TBL] [Abstract][Full Text] [Related]
13. Identification of small molecule inhibitors of the mitotic kinase haspin by high-throughput screening using a homogeneous time-resolved fluorescence resonance energy transfer assay.
Patnaik D; Jun Xian ; Glicksman MA; Cuny GD; Stein RL; Higgins JM
J Biomol Screen; 2008 Dec; 13(10):1025-34. PubMed ID: 18978305
[TBL] [Abstract][Full Text] [Related]
14. Haspin: a newly discovered regulator of mitotic chromosome behavior.
Higgins JM
Chromosoma; 2010 Apr; 119(2):137-47. PubMed ID: 19997740
[TBL] [Abstract][Full Text] [Related]
15. Haspin inhibition delays cell cycle progression through interphase in cancer cells.
Wang P; Hua X; Bryner YH; Liu S; Gitter CB; Dai J
J Cell Physiol; 2020 May; 235(5):4508-4519. PubMed ID: 31625162
[TBL] [Abstract][Full Text] [Related]
16. Halogen Bonding in Haspin-Halogenated Tubercidin Complexes: Molecular Dynamics and Quantum Chemical Calculations.
Zhou Y; Wong MW
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163974
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin.
Huertas D; Soler M; Moreto J; Villanueva A; Martinez A; Vidal A; Charlton M; Moffat D; Patel S; McDermott J; Owen J; Brotherton D; Krige D; Cuthill S; Esteller M
Oncogene; 2012 Mar; 31(11):1408-18. PubMed ID: 21804608
[TBL] [Abstract][Full Text] [Related]
18. Design of new disubstituted imidazo[1,2-
Elie J; Feizbakhsh O; Desban N; Josselin B; Baratte B; Bescond A; Duez J; Fant X; Bach S; Marie D; Place M; Ben Salah S; Chartier A; Berteina-Raboin S; Chaikuad A; Knapp S; Carles F; Bonnet P; Buron F; Routier S; Ruchaud S
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1840-1853. PubMed ID: 33040634
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship study of beta-carboline derivatives as haspin kinase inhibitors.
Cuny GD; Ulyanova NP; Patnaik D; Liu JF; Lin X; Auerbach K; Ray SS; Xian J; Glicksman MA; Stein RL; Higgins JM
Bioorg Med Chem Lett; 2012 Mar; 22(5):2015-9. PubMed ID: 22335895
[TBL] [Abstract][Full Text] [Related]
20. Loss of haspin suppresses cancer cell proliferation by interfering with cell cycle progression at multiple stages.
Wang P; Hua X; Sun Y; Li H; Bryner YH; Hsung RP; Dai J
FASEB J; 2021 Oct; 35(10):e21923. PubMed ID: 34551143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
